The Problem of Unpatentable  Innovation in Pharmaceuticals

The Problem of Unpatentable Innovation in Pharmaceuticals

As capital intensive public goods, pharmaceuticals are likely to receive inefficiently-low investment in the absence of government intervention. The patent system functions well to promote innovation in the pharmaceutical industry. However, because innovation in...
iLawyer

iLawyer

Artificially intelligent technologies have entered the United States legal market—and it appears they are here to stay. In 2019 alone, investments in legal technology amounted to over 1.2 billion dollars. Presently, AI legal tools fall into six major categories: (1)...
Unresolved Means-Plus-Function  Issues Post-Williamson

Unresolved Means-Plus-Function Issues Post-Williamson

What are the benefits of means-plus-function claiming? Claims written this way allow the patentee to describe their invention in terms of a “step” or “means” for performing a specified function without limiting the patent scope to the specific structures disclosed in...